Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient
| Status: | No longer available |
|---|---|
| Conditions: | Ovarian Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
Expanded Access Protocol to Provide Ficlatuzumab to P05538 Patient 0001-000412
Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient
This treatment protocol will serve as a mechanism to continue to provide ficlatuzumab to
patient 0001-000412, who was previously enrolled under protocol P05538 and whom the
investigator believes is deriving clinical benefit from ficlatuzumab treatment.
patient 0001-000412, who was previously enrolled under protocol P05538 and whom the
investigator believes is deriving clinical benefit from ficlatuzumab treatment.
Inclusion Criteria:
- Per original P05538 protocol
Exclusion Criteria:
- Per original P05538 protocol
We found this trial at
1
site
